Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360789/
https://www.ncbi.nlm.nih.gov/pubmed/25792842
http://dx.doi.org/10.2147/OTT.S80592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360789/
https://www.ncbi.nlm.nih.gov/pubmed/25792842
http://dx.doi.org/10.2147/OTT.S80592

Ejemplares similares